BR100 Increased By (0.03%)
BR30 Increased By (0.07%)
KSE100 Increased By (0.04%)
KSE30 Increased By (0.04%)
AGHA 6.52 Increased By ▲ 0.20 (3.16%)
BECO 4.40 Increased By ▲ 0.13 (3.04%)
BML 62.40 Decreased By ▼ -0.05 (-0.08%)
BOP 31.40 Increased By ▲ 0.17 (0.54%)
CNERGY 11.75 Increased By ▲ 0.16 (1.38%)
CSIL 6.01 Increased By ▲ 0.29 (5.07%)
FCCL 60.67 Decreased By ▼ -0.87 (-1.41%)
FFL 14.90 Decreased By ▼ -0.12 (-0.8%)
FNEL 1.25 Increased By ▲ 0.02 (1.63%)
KEL 6.29 Increased By ▲ 0.03 (0.48%)
KOSM 5.76 Increased By ▲ 0.20 (3.6%)
LOTCHEM 24.75 Increased By ▲ 0.07 (0.28%)
MLCF 102.81 Decreased By ▼ -1.27 (-1.22%)
NBP 174.50 Decreased By ▼ -0.78 (-0.45%)
NCPL 52.99 Increased By ▲ 0.22 (0.42%)
NPL 54.67 Increased By ▲ 0.55 (1.02%)
OGDC 313.94 Increased By ▲ 0.55 (0.18%)
PACE 9.28 Increased By ▲ 0.08 (0.87%)
PAEL 35.50 Decreased By ▼ -0.30 (-0.84%)
PIBTL 13.65 Increased By ▲ 0.18 (1.34%)
PPL 222.00 Increased By ▲ 0.19 (0.09%)
PRL 80.34 Increased By ▲ 1.26 (1.59%)
PTC 47.01 Increased By ▲ 0.16 (0.34%)
SSGC 23.96 Increased By ▲ 0.09 (0.38%)
TBL 9.27 Decreased By ▼ -0.04 (-0.43%)
TELE 7.47 Increased By ▲ 0.08 (1.08%)
TPL 24.70 Decreased By ▼ -0.41 (-1.63%)
TPLP 12.97 Increased By ▲ 0.46 (3.68%)
TREET 26.10 Decreased By ▼ -0.15 (-0.57%)
TRG 54.34 Increased By ▲ 0.90 (1.68%)

The United States on Friday announced it was funding development of rapid diagnostic kits for the novel coronavirus as people across the country reported they were unable to get tested for the illness because of shortages.

US authorities have come under fire for lagging behind in deploying test kits, which leading health experts have said allowed the virus to spread beyond the country's ability to detect it. The Department of Health and Human Services (HHS) said Friday it was providing almost $1.3 million in funding to two labs to develop tests that return results in about one hour. At present results generally take several days.

The HHS said it was providing almost $700,000 to DiaSorin Molecular of California and just under $600,000 to QIAGEN of Maryland to develop the tests, but provided no timeline about when these would be available.

As of Friday morning there were more than 1,700 confirmed US cases and 40 deaths, according to a Johns Hopkins University tracker. At the start of the outbreak testing was only occurring at the headquarters of the Centers for Disease Control (CDC). The CDC then started sending its kits out to state labs, but the first batches were faulty and had to be modified.

Regulatory hurdles meant that state authorities were prevented from developing and using their own tests based on protocols provided by the World Health Organization.

These roadblocks were finally lifted on February 29, a month after the first US case, and private laboratories including major players LabCorp and Quest have announced their kits have entered the market.

But on the ground, people are still reporting they are unable to be tested - even when clinical signs suggest they have the pathogen. Earlier this week Vice President Mike Pence said that through a combination of government and private efforts a million test kits had now been deployed and millions more were on the way - figures that were later revealed to be misleading because these kits still lack vital components to activate them.

Copyright Agence France-Presse, 2020

Comments

Comments are closed for this article.